Tumor growth and metastasis can be inhibited by maintaining genomic stability in cancer cells

Abstract

The existence of cancer stem cells, stem-like cancer cells (SLCCs), or tumor-initiating cells is considered as the cause of tumor formation and recurrence, indicating the importance of studying novel therapy that targets SLCCs. The origin of SLCCs is controversial because of two competing hypotheses: SLCCs are either transformed from tissue adult stem cells or dedifferentiated from transformed progenitor cells. Our previous research demonstrates that SLCCs are inducible by increasing genomic instability in cancer cells. In this study, to block the emergence of SLCCs, aminoethyl isothiourea (AET), a compound that clears free radicals and is used to protect patients from radioactive exposure, was used as an agent that maintains genomic stability in combination with mitomycin C (MMC), a commonly used chemotherapeutic drug that damages DNA. Using a rabbit tumor model with VX2 hepatic carcinoma, we found that MMC alone increased lung metastases and disadvantaged survival outcome, but the combination of MMC and AET reversed this effect and even prolonged overall survival. Moreover, in a VX2 xenograft model by immunocompromised mice, MMC alone enriched tumor-initiating cells, but the administration of MMC in combination with AET eliminated tumor cells effectively. Furthermore, MMC alone enhanced genomic instability, but MMC combined with AET attenuated the extent of genomic instability in primary VX2 tumor tissue. Taken together, our data suggest that the genomic protector AET can inhibit the induction of SLCCs, and this combination treatment by AET and cytotoxic agents should be considered as a promising strategy for future clinical evaluation.

Keywords

rabbit VX2 liver tumor / mitomycin C / AET / stem-like cancer cells / genomic instability

References

[1] Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med2004; 10(8): 789-799

[2] Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature2001; 414(6859): 105-111

[3] Houghton J, Morozov A, Smirnova I, Wang TC. Stem cells and cancer. Semin Cancer Biol2007; 17(3): 191-203

[4] Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, Liu Q, Pei D, Kang T, Zeng YX. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem2010; 285(7): 4931-4940

[5] Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer2005; 5(4): 275-284

[6] Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol2012; 22(5-6): 396-403

[7] Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science2011; 331(6024): 1559-1564

[8] DiStefano V. Some Remarks on the Pharmacology of Radioprotectant Agents. Ann N Y Acad Sci1964; 114(1): 588-596

[9] Carr CJ, Huff JE, Fisher KD, Huber TE. Protective agents modifying biological effects of radiation. A selective review. Arch Environ Health1970; 21(1): 88-98

[10] Akoun G. Pharmacologic and clinical study of 2-amino-ethyl-isothiouronium hydrobromide: utilization in neurologic therapy. Psychiatr Neurol Neurochir1964; 67: 278-288 (in French)

[11] Kidd JG, Rous P. A Transplantable Rabbit Carcinoma Originating in a Virus-Induced Papilloma and Containing the Virus in Masked or Altered Form. J Exp Med1940; 71(6): 813-838

[12] Nishizaki T, Matsumata T, Kanematsu T, Yasunaga C, Sugimachi K. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res1990; 49(1): 92-97

[13] Wang Z, Yang G, Nie P, Fu J, Wang X, Liu D. Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. PLoS ONE2013; 8(8): e74327

[14] Tomasz M. Mitomycin C: small, fast and deadly (but very selective). Chem Biol1995; 2(9): 575-579

[15] Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell2007; 131(6): 1109-1123

[16] Laborit H, Broussolle B, Jouany JM, Niaussat P, Reynier M, Weber B. Pharmacological study of 2-aminoethylisothiuronium hydrobromide (AET). Therapie1959; 14: 1116-1135 (in French)

[17] Anderson DR. The radiation protective effects of AET on the enzyme creatine phosphokinase. Arch Biochem Biophys1959; 81(2): 390-394

[18] Doherty DG, Burnett WT Jr. Protective effect of S, beta-aminoethylisothiuronium-Br-HBr and related compounds against x-radiation death in mice. Proc Soc Exp Biol Med1955; 89(2): 312-314

[19] Crouch BG, Overman RR. Chemical protection against x-radiation death in primates: a preliminary report. Science1957; 125(3257): 1092

[20] Pritsos CA, Sartorelli AC. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res1986; 46(7): 3528-3532

Rights & permissions

Higher Education Press and Springer-Verlag Berlin Heidelberg